Page last updated: 2024-11-01

niclosamide and Liver Steatosis

niclosamide has been researched along with Liver Steatosis in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
"Niclosamide is an anthelmintic drug approved by the US Food and Drug Administration that uncouples the mitochondria of parasitic worms."1.40Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. ( Jin, S; Shulman, GI; Tao, H; Zeng, X; Zhang, Y, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tao, H1
Zhang, Y1
Zeng, X1
Shulman, GI1
Jin, S1

Other Studies

1 other study available for niclosamide and Liver Steatosis

ArticleYear
Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.
    Nature medicine, 2014, Volume: 20, Issue:11

    Topics: Administration, Oral; Animals; Blood Glucose; Cell Respiration; Diabetes Mellitus, Experimental; Die

2014